CIK 0001689375 · Accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entrada Therapeutics, Inc.
Sign in to watch- Ticker
- TRDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 813983399
- Phone
- 857-305-1825
- Business address
- ONE DESIGN CENTER PLACE, SUITE 17-500, BOSTON, MA, 02210
- Former names
- CycloPorters, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,200,939
- in 8 filings
Net −$7,200,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-01 | 5AM Ventures V, L.P. 10% owner | Sale | −6,422 | $7.12 | $46K | 1,100,248 |
| 2025-06-30 | PARMAR KUSH Director | Sale | −18,578 | $6.81 | $127K | 3,201,709 |
| 2025-06-30 | PARMAR KUSH Director | Sale | −6,422 | $6.81 | $44K | 1,106,670 |
| 2025-06-30 | 5AM Ventures V, L.P. 10% owner | Sale | −18,578 | $6.81 | $127K | 3,201,709 |
| 2025-06-30 | 5AM Ventures V, L.P. 10% owner | Sale | −6,422 | $6.81 | $44K | 1,106,670 |
| 2025-06-27 | PARMAR KUSH Director | Sale | −55,735 | $6.91 | $385K | 3,220,287 |
| 2025-06-27 | PARMAR KUSH Director | Sale | −19,265 | $6.91 | $133K | 1,113,092 |
| 2025-06-27 | 5AM Ventures V, L.P. 10% owner | Sale | −55,735 | $6.91 | $385K | 3,220,287 |
| 2025-06-27 | 5AM Ventures V, L.P. 10% owner | Sale | −19,265 | $6.91 | $133K | 1,113,092 |
| 2025-06-11 | PARMAR KUSH Director | Grant or award · Stock Option (Right to Buy) | +19,000 | 19,000 | ||
| 2025-06-11 | KIM PETER S Director | Grant or award · Stock Option (Right to Buy) | +19,000 | 19,000 | ||
| 2025-06-11 | Thistle Mary Director | Grant or award · Stock Option (Right to Buy) | +19,000 | 19,000 | ||
| 2025-06-11 | Zeiher Bernhardt G Director | Grant or award · Stock Option (Right to Buy) | +19,000 | 19,000 | ||
| 2025-06-11 | Chapman Gina Director | Grant or award · Stock Option (Right to Buy) | +19,000 | 19,000 | ||
| 2025-06-01 | Radhakrishnan Maha Director | Grant or award · Stock Option (Right to Buy) | +38,000 | 38,000 | ||
| 2025-04-03 | WENTWORTH KORY JAMES Chief Financial Officer | Option exercise | +11,134 | $2.10 | $23K | 120,670 |
| 2025-04-03 | WENTWORTH KORY JAMES Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −11,134 | 20,023 | ||
| 2025-03-17 | WENTWORTH KORY JAMES Chief Financial Officer | Sale 10b5-1 | −1,784 | $10.67 | $19K | 109,536 |
| 2025-03-03 | Doshi Dipal CEO | Shares withheld for taxes | −17,566 | $11.68 | $205K | 424,387 |
| 2025-03-03 | WENTWORTH KORY JAMES Chief Financial Officer | Shares withheld for taxes | −4,929 | $11.68 | $58K | 111,320 |
Page 6 of 12 · 230 trades